» Articles » PMID: 27194770

Functional Incompatibility Between the Generic NF-κB Motif and a Subtype-Specific Sp1III Element Drives the Formation of the HIV-1 Subtype C Viral Promoter

Overview
Journal J Virol
Date 2016 May 20
PMID 27194770
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Of the various genetic subtypes of human immunodeficiency virus types 1 and 2 (HIV-1 and HIV-2) and simian immunodeficiency virus (SIV), only in subtype C of HIV-1 is a genetically variant NF-κB binding site found at the core of the viral promoter in association with a subtype-specific Sp1III motif. How the subtype-associated variations in the core transcription factor binding sites (TFBS) influence gene expression from the viral promoter has not been examined previously. Using panels of infectious viral molecular clones, we demonstrate that subtype-specific NF-κB and Sp1III motifs have evolved for optimal gene expression, and neither of the motifs can be replaced by a corresponding TFBS variant. The variant NF-κB motif binds NF-κB with an affinity 2-fold higher than that of the generic NF-κB site. Importantly, in the context of an infectious virus, the subtype-specific Sp1III motif demonstrates a profound loss of function in association with the generic NF-κB motif. An additional substitution of the Sp1III motif fully restores viral replication, suggesting that the subtype C-specific Sp1III has evolved to function with the variant, but not generic, NF-κB motif. A change of only two base pairs in the central NF-κB motif completely suppresses viral transcription from the provirus and converts the promoter into heterochromatin refractory to tumor necrosis factor alpha (TNF-α) induction. The present work represents the first demonstration of functional incompatibility between an otherwise functional NF-κB motif and a unique Sp1 site in the context of an HIV-1 promoter. Our work provides important leads as to the evolution of the HIV-1 subtype C viral promoter with relevance for gene expression regulation and viral latency.

Importance: Subtype-specific genetic variations provide a powerful tool to examine how these variations offer a replication advantage to specific viral subtypes, if any. Only in subtype C of HIV-1 are two genetically distinct transcription factor binding sites positioned at the most critical location of the viral promoter. Since a single promoter regulates viral gene expression, the promoter variations can play a critical role in determining the replication fitness of the viral strains. Our work for the first time provides a scientific explanation for the presence of a unique NF-κB binding motif in subtype C, a major HIV-1 genetic family responsible for half of the global HIV-1 infections. The results offer compelling evidence that the subtype C viral promoter not only is stronger but also is endowed with a qualitative gain-of-function advantage. The genetically variant NF-κB and the Sp1III motifs may be respond differently to specific cell signal pathways, and these mechanisms must be examined.

Citing Articles

Proximity Ligation Assay to Detect the Proximity Between Host Proteins and Viral Proteins of HIV-1.

Chakraborty S, Suresh S, Buch H, Panchapakesan A, Ranga U Methods Mol Biol. 2024; 2807:245-258.

PMID: 38743233 DOI: 10.1007/978-1-0716-3862-0_17.


Genetic variation of the HIV-1 subtype C transmitted/founder viruses long terminal repeat elements and the impact on transcription activation potential and clinical disease outcomes.

Madlala P, Mkhize Z, Naicker S, Khathi S, Maikoo S, Gopee K PLoS Pathog. 2023; 19(6):e1011194.

PMID: 37307292 PMC: 10289673. DOI: 10.1371/journal.ppat.1011194.


Enhanced Transcriptional Strength of HIV-1 Subtype C Minimizes Gene Expression Noise and Confers Stability to the Viral Latent State.

Pal S, Jaiswal V, Nala N, Ranga U J Virol. 2022; 97(1):e0137622.

PMID: 36533949 PMC: 9888270. DOI: 10.1128/jvi.01376-22.


Selective elimination of host cells harboring replication-competent human immunodeficiency virus reservoirs: a promising therapeutic strategy for HIV cure.

Zaongo S, Wang Y, Ma P, Song F, Chen Y Chin Med J (Engl). 2021; 134(23):2776-2787.

PMID: 34620750 PMC: 8667983. DOI: 10.1097/CM9.0000000000001797.


An emerging and variant viral promoter of HIV-1 subtype C exhibits low-level gene expression noise.

Ali H, Bhange D, Mehta K, Gohil Y, Prajapati H, Byrareddy S Retrovirology. 2021; 18(1):27.

PMID: 34538278 PMC: 8451104. DOI: 10.1186/s12977-021-00572-2.


References
1.
Siddappa N, Dash P, Mahadevan A, Desai A, Jayasuryan N, Ravi V . Identification of unique B/C recombinant strains of HIV-1 in the southern state of Karnataka, India. AIDS. 2005; 19(13):1426-9. DOI: 10.1097/01.aids.0000180795.49016.89. View

2.
Regier D, Desrosiers R . The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus. AIDS Res Hum Retroviruses. 1990; 6(11):1221-31. DOI: 10.1089/aid.1990.6.1221. View

3.
van Opijnen T, Kamoschinski J, Jeeninga R, Berkhout B . The human immunodeficiency virus type 1 promoter contains a CATA box instead of a TATA box for optimal transcription and replication. J Virol. 2004; 78(13):6883-90. PMC: 421681. DOI: 10.1128/JVI.78.13.6883-6890.2004. View

4.
Pessler F, Cron R . Reciprocal regulation of the nuclear factor of activated T cells and HIV-1. Genes Immun. 2004; 5(3):158-67. DOI: 10.1038/sj.gene.6364047. View

5.
Roof P, Ricci M, Genin P, Montano M, Essex M, Wainberg M . Differential regulation of HIV-1 clade-specific B, C, and E long terminal repeats by NF-kappaB and the Tat transactivator. Virology. 2002; 296(1):77-83. DOI: 10.1006/viro.2001.1397. View